Stockreport

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF Proceeds from the royalty interest financing expected to fully fund U.S. commercial launch of taletrectinib Pro forma cash balance expected to fully fund development [Read more]